Globally, anaemia, iron deficiency and infections are responsible for a majority of the morbidity and mortality that occurs among children. As iron is essential for erythropoiesis and the human immune system, as well as a crucial element for many pathogens, these three conditions often interact. This article considers the question -have the studies conducted so far unravelled the potential complex interaction between these factors sufficiently enough to be able to develop universally applicable guidelines about iron treatment in children? It is possible, however, that the area is too complex and diverse, with many sub-populations, and that not universal, but tailor-made guidelines are needed based on some agreed principles.
Anaemia, iron deficiency and infections are responsible for a large part of the global morbidity and mortality that occurs in children aged less than 5 years old. This is especially true for resource-limited settings, such as sub-Saharan Africa, where the three conditions often interact. For example, iron deficiency may, apart from leading to anaemia, increase the susceptibility to infection by suppressing the immunological response to pathogens (Beard, 2001) . However, iron deficiency may also protect the host against infections, such as malaria (Gwamaka et al, 2012; Jonker et al, 2012a) . This multidirectional relationship between iron status and infection risk has been subject to many studies. After a short introduction on anaemia, iron metabolism and its relationship with infections, this article will highlight some interesting research questions that arise from the complex interaction between anaemia, iron deficiency and infections.
Anaemia
Anaemia is a global public health problem, especially affecting young children with prevalence up to 70% in some populations (World Health Organisation, 2005) . As for anaemia in children living in western countries, the underlying mechanisms leading to the development of anaemia are often classified as increased red blood cell destruction, impaired red blood cell production and/or acute or chronic blood loss, yet the actual underlying aetiologies are different for children living in tropical and research-poor settings, such as Sub Saharan Africa (Table I) . Anaemia should be considered a syndrome rather than a specific disease, because multiple aetiologies may trigger one or more of these three mechanisms leading to severe anaemia (Calis et al, 2008) . Iron deficiency is often considered the primary cause of (severe) anaemia. As a result, the terms anaemia, iron deficiency and iron deficiency anaemia are often interchanged. This is incorrect as anaemia can occur with sufficient iron stores and iron deficiency in the initial phase does not necessarily lead to anaemia. Other aetiological factors include: infections, such as malaria (Menendez et al, 2000) , hookworm (Jonker et al, 2012b) and human immunodeficiency virus (HIV) (World Health Organisation, 2005) ; drugs, such as antibiotics (KnoxMacaulay, 1992; Ahmed & Ibrahim, 2001 ) and anti-retrovirals (Shah, 2006) ; genetic disorders, such as glucose-6-phosphate dehydrogenase deficiency, alpha-thalassaemia and sickle cell disease (Flint et al, 1998) ; and micronutrient deficiencies (iron, vitamin B12, folic acid and vitamin A) all of which may cause, or contribute to the severity of, anaemia.
Iron status

Iron deficiency
Despite the mechanisms to ensure the integrity of the body's iron homeostasis, many factors can induce iron deficiency (Fig 1) . An increased demand during periods of rapid growth (e.g. first years of life) and/or inadequate diet (which is associated with low socio-economic status) are probably the most important causes of childhood iron deficiency in areas like sub-Saharan Africa, with limited iron bioavailability from staple foods (World Health Organisation, 2005) . In these areas with a high infectious pressure and inadequate health services, gastrointestinal blood loss due to enteric parasitic infections, including hookworm, is also an important cause of iron deficiency (Albonico et al, 1998; Jonker et al, 2012b) . In addition to true iron shortage in body stores, the physiological systems for iron transport to target tissues may be impaired in the presence of adequate iron stores (World Health Organisation, 2004 ). This condition is called functional iron deficiency and is caused by cytokine release during the acute phase response to infection and, among others, mediated by hepcidin (Kroot et al, 2011) . When iron is not available due to either true or functional iron deficiency, iron delivery to the bone marrow becomes insufficient to uphold adequate haemoglobin synthesis, resulting in iron deficiency anaemia. Besides causing anaemia, iron deficiency may also lead to impaired cognitive development of the child (Beard, 2001; World Health Organisation, 2002) .
The measurement of iron during infection
The Perl's Prussian blue stained bone marrow aspirate is recognised as the 'gold standard' for assessing iron status (Burns et al, 1990) . However, it is an invasive method and therefore often not performed. Besides this, the true value of this assessment as reference standard may be questioned as the quantity of stored iron is not necessarily equal to the quantity of available iron. Currently, instead of bone marrow assessment for the determination of iron levels, often biomarkers detectable in serum are used. Their predictive value is often limited by infection, as most iron biomarkers act as acute-phase-proteins. To bypass this confounding effect, some studies adjust their cut-off values using inflammatory markers (C-reactive protein or alpha-1-acid glycoprotein) as correcting factors (Esan et al, 2013; Le Nguyen Bao et al, 2016; Suchdev et al, 2016) , whereas others have made use of iron biomarkers that are less affected by inflammation (e.g. serum transferrin receptor, zinc protoporphyrin) (Wander et al, 2009). However, even those biomarkers are not free from the influence of infection (Beesley et al, 2000) . Several studies compared different iron biomarkers for the detection of iron deficiency (anaemia) in the presence of inflammation. However, all of the iron biomarkers tested showed a large number of false positive and false negative detections (Phiri et al, 2009; Jonker et al, 2014) : the need for a reliable biomarker to assess iron status remains.
Iron and infection
Iron deficiency and impaired immunity
Iron deficiency is thought to impair immunity by negatively influencing cell-mediated immunity and components of the human innate immune system. For example, iron deficiency has also been associated with thymic atrophy, the depression of T-lymphocytes, decreased neutrophil function, a decrease in the microbicidal qualities of macrophages (Kumar & Choudhry, 2010; Drakesmith & Prentice, 2012) and reduced interleukin-2 production by activated lymphocytes (Galan et al, 1992) . In Malawian HIV-infected anaemic children receiving iron supplementation, an increase in the number of circulating CD4 positive T-cells was observed (Esan et al, 2013) .
Iron and pathogens
Besides being an essential element for human metabolism, iron is also an important nutrient for pathogenic microorganisms. Pathogens are able to sequester iron from the host, depending on the preferred iron source and whether the pathogen adopts a predominately intracellular or extracellular lifestyle (Cassat & Skaar, 2013) . One of the mechanisms used by several bacteria and fungi is the secretion of iron-chelating siderophores. Siderophore receptors expressed on the membranes of pathogens pick up the siderophore-bound iron (Drakesmith & Prentice, 2012) and compete with the iron binding sites of the human host (Kumar & Choudhry, 2010) .
Iron deficiency as an immune defence
As iron may be needed for pathogen functioning, a way for the host to protect itself from worsening infections is to (Hadley & DeCaro, 2015) . This iron withholding response to microbial invasion -hypoferraemia of infection or functional iron deficiency -is mainly induced by hepcidin, a small amino acid primarily synthesized by hepatocytes (Nicolas et al, 2001; Park et al, 2001; Pigeon et al, 2001) , as well as by several other cells, although in much lower quantities (Kroot et al, 2011) . It exercises its effect on iron metabolism by binding to the iron transporter ferroportin (FPN), internalizing and degrading it and thereby regulating iron efflux (Nemeth et al, 2004) . FPN is primarily expressed in intestinal enterocytes,but also in all cell types exporting iron into plasma: macrophages of the reticuloendothelial system, placental trophoblasts and cells of the central nervous system (D'Anna et al, 2009). Hepcidin binds to FPN at the basolateral membrane of enterocytes, which are the site of dietary iron absorption, preventing iron from entering the bloodstream. Furthermore, hepcidin causes retention of iron in macrophages by binding to FPN on the surface of macrophages, thereby promoting accumulation of intracellular iron (Nemeth et al, 2004) . Hepcidin is up-regulated in response to increased iron levels, as well as inflammatory stimuli, which generates functional iron deficiency and restricts available iron for pathogenic utilization. Downregulation of hepcidin occurs in the context of reduced iron levels, hypoxia and increased erythropoiesis (Kroot et al, 2011) . Moreover, besides systemic effects, at the site of infection the iron binding proteins lactoferrin (e.g. present in breast milk and released by neutrophils), transferrin and ferritin act as acute-phase proteins as part of the innate immune system, through sequestering iron at the site of infection and thereby withholding iron from pathogens (Drakesmith & Prentice, 2012) . Pathogens have evolved mechanisms to sequester iron from its host as mentioned in the previous paragraph, yet at the same time the human body has developed mechanisms that anticipate this scavenge; the answer to the siderophore secretion by pathogens is the protein siderocalin, which binds iron-binding sites of siderophores, interrupting pathogenic iron-acquisition (Holmes et al, 2005) . Furthermore, the diversion of serum iron into cells like macrophages in response to extracellular pathogen stimuli could be beneficial for intracellular pathogens, such as Salmonella species (Van Santen et al, 2013) . Subsequently, the host expresses Natural Resistance Associated Macrophage Proteins, or NRAMPs, that target microbecontaining phagosomes within macrophages and monocytes (Kumar & Choudhry, 2010) , depleting them of iron, which restricts the growth of intracellular pathogens (Burt e et al, 2013).
Iron supplementation and infection
According to the Global Burden of Disease studies (1990 and 2013) iron-deficiency anaemia is a primary cause of "years lived with disability" among children and adolescents (Global Burden of Disease Pediatrics Collaboration, 2016). Therefore, until recently many global guidelines advocated iron supplementation to all children living in regions with a high prevalence of iron deficiency (World Health Organisation, 2002) . However, in 2006 a large trial in Tanzania raised concerns that iron supplementation could increase risk of malariarelated morbidity and mortality (Sazawal et al, 2006) . A positive correlation between supplemental iron and subsequent increased infection risk had already been described in the late 1970s (Murray et al, 1978) , yet this correlation was never considered to outweigh the benefits of iron supplementation. However, after the Tanzanian trial, the WHO advised withholding iron supplementation from iron-replete children (World Health Organisation, 2007) . In addition, some studies also have also found that iron supplementation could adversely affect the gut microbiota (Zimmerman et al, 2010; Jaeggi et al, 2015) .
The Dilemma
In most tropical areas both infections and anaemia are highly endemic in children. Iron supplementation plays an important role in anaemia treatment and prevention programmes. As iron is not only an essential element of haemoglobin and the human immune system but is also required for the function of many pathogens, maintaining equilibrium between the provision of sufficient iron for optimal function of human biological systems while withholding it from pathogens, is critical. Several studies have examined the relationship between susceptibility to infections and the host iron status and/or iron supplementation. Where some authors found adverse effects of iron supplementation and/or a protective effect of iron deficient status, others reported a decreased risk of infections after iron supplementation. The largest meta-analysis, conducted as a Cochrane review on iron supplementation in children in malaria endemic areas (Neuberger et al, 2016) , concluded that iron supplementation was safe if malaria prevention and treatment was guaranteed. As a result, the WHO very recently adjusted their recommendations; now advising that daily iron supplementation should be given to all children living in areas with high prevalence of anaemia provided that, if malaria is endemic, malaria prevention is guaranteed (World Health Organisation, 2016) . However, there are some outstanding issues to be resolved before these WHO recommendations can be used as a universal international guideline. The findings of Neuberger et al (2016) are limited because most studies included in the review were lacking a suitable screening marker for iron status: as a result the relationship between iron supplementation, iron status and infection risk could not be analysed properly. This is of importance, because other studies have shown base line iron status to be a predictor for malaria risk (Jonker et al, 2012a; Clark et al, 2014) .
Contradicting results from studies investigating infection risk and iron supplementation may be explained by the fact that the type of pathogen and prevalence of various type of infections may influence the infection risk (the higher the prevalence, the larger the influence). The host's genetic background (McDermid & Prentice, 2006) might also be an explaining factor. Furthermore, the intra-or extracellular location of pathogens and iron in the body may give different outcomes. This is shown by studies on Mycobacterium tuberculosis and non-typhoid Salmonella (NTS). For example, in cases of enhanced erythrophagocytosis and inflammation, the iron content of macrophages increases and thereby also the survival of intracellular Salmonella spp. (Van Santen et al, 2013) . Age may also be a factor influencing infections risk, as children under 2 years seemed to have less malaria after iron supplementation compared to other age groups; confounding other interventions, for example in the Cochrane review an increase in incidence of diarrheal was found in the iron-supplemented group which could later be attributed to the addition of zinc to the iron supplementation (Neuberger et al, 2016) .
Another dilemma is that has been raised is that oral iron supplementation to treat iron deficiency in the presence of concurrent infection is pointless, as hepcidin upregulation inhibits the iron uptake in the gut (Casals-Pascual et al, 2012) . This was supported by a study showing that malaria infection results in 50% reduction in the amount of iron absorbed (Glinz et al, 2015) . Hepcidin levels could therefore be used to indicate whether or not iron supplements should be used. Wegm€ uller et al (2016) planned a promising double blind, randomized controlled trial involving mildly anaemic children aged 6-23 months to assess the use of hepcidin as a point-of-care screening test to decide whether to treat with iron or not. However, any findings may not apply to severely anaemic children as in this population the up-regulation during inflammation can be overruled by the down-regulation through erythropoietin; iron would then be absorbed during concurrent infection, possibly increasing the virulence of the present pathogen (Jonker et al, 2013) .
Conclusion
The equilibrium between human iron status and infection risk is complex, and maintaining the optimal balance for human health depends on population-and context-specific factors. This makes it very difficult, and possibly inappropriate, to develop and apply generic (global) iron treatment guidelines. A more nuanced approach for iron supplementation will depend on the ability to predict the safety of iron supplementation in specific sub-populations. However, a reliable laboratory test for iron status is needed in order to properly define these sub-populations. In addition, hepcidin as a point-of-care test may help to predict iron absorption, but may not be applicable in sub-populations, such as severely anaemic children. Tools to identify these subpopulations are a research priority and will eventually help to replace the universal guidelines for iron treatment by a more tailored, area-/population-specific guidelines.
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